News Wire

Guidance emphasizes individualized treatment
Hospitals, insurers, and businesses prod drug-makers
Product overcomes patent-infringement lawsuit
Nonprofit group issues safety score update
Approval decision expected by May 26
Treatment demonstrates superior improvement in lung function versus mono-components and placebo
Therapy improves overall survival, progression-free survival, and objective response rate in phase 3 trial
Hospitals should be alert for signs of infection, expert says

Pages